Free Trial

Stryker (SYK) Competitors

Stryker logo
$389.02 -1.85 (-0.47%)
Closing price 07/17/2025 03:59 PM Eastern
Extended Trading
$388.84 -0.19 (-0.05%)
As of 07/17/2025 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SYK vs. ISRG, BSX, CAH, COR, DVA, MDT, ZBH, ABT, BDX, and EW

Should you be buying Stryker stock or one of its competitors? The main competitors of Stryker include Intuitive Surgical (ISRG), Boston Scientific (BSX), Cardinal Health (CAH), Cencora (COR), DaVita (DVA), Medtronic (MDT), Zimmer Biomet (ZBH), Abbott Laboratories (ABT), Becton, Dickinson and Company (BDX), and Edwards Lifesciences (EW). These companies are all part of the "medical" sector.

Stryker vs. Its Competitors

Intuitive Surgical (NASDAQ:ISRG) and Stryker (NYSE:SYK) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation.

In the previous week, Intuitive Surgical had 21 more articles in the media than Stryker. MarketBeat recorded 63 mentions for Intuitive Surgical and 42 mentions for Stryker. Stryker's average media sentiment score of 1.43 beat Intuitive Surgical's score of 1.28 indicating that Stryker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intuitive Surgical
52 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Stryker
38 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 5.9% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Intuitive Surgical has a net margin of 28.41% compared to Stryker's net margin of 12.31%. Stryker's return on equity of 23.74% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intuitive Surgical28.41% 14.43% 12.81%
Stryker 12.31%23.74%11.25%

Intuitive Surgical has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Comparatively, Stryker has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500.

Stryker has higher revenue and earnings than Intuitive Surgical. Stryker is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$8.35B22.15$2.32B$6.8275.68
Stryker$22.60B6.57$2.99B$7.4052.57

Intuitive Surgical currently has a consensus price target of $592.86, suggesting a potential upside of 14.86%. Stryker has a consensus price target of $428.55, suggesting a potential upside of 10.16%. Given Intuitive Surgical's higher possible upside, equities analysts clearly believe Intuitive Surgical is more favorable than Stryker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical
1 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.70
Stryker
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.79

Summary

Intuitive Surgical beats Stryker on 8 of the 15 factors compared between the two stocks.

Get Stryker News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SYK vs. The Competition

MetricStrykerMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$149.19B$10.32B$5.57B$20.75B
Dividend Yield0.86%2.05%3.80%3.67%
P/E Ratio52.5716.3128.1027.60
Price / Sales6.5729.26441.4159.14
Price / Cash25.9122.2635.8422.13
Price / Book7.193.618.264.66
Net Income$2.99B$233.40M$3.24B$994.58M
7 Day Performance-0.06%-1.11%1.48%0.00%
1 Month Performance4.24%3.68%8.07%5.25%
1 Year Performance17.44%-15.76%30.29%10.76%

Stryker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYK
Stryker
4.7859 of 5 stars
$389.02
-0.5%
$428.55
+10.2%
+16.3%$149.19B$22.60B52.5753,000Positive News
ISRG
Intuitive Surgical
4.6601 of 5 stars
$518.47
+1.3%
$592.86
+14.3%
+21.1%$185.82B$8.35B76.0215,638Trending News
Upcoming Earnings
Analyst Revision
BSX
Boston Scientific
4.6449 of 5 stars
$104.46
+1.2%
$116.09
+11.1%
+35.1%$154.54B$16.75B76.2553,000Trending News
Upcoming Earnings
CAH
Cardinal Health
4.878 of 5 stars
$161.58
+0.4%
$157.43
-2.6%
+66.1%$38.56B$222.29B25.2048,900Positive News
Analyst Forecast
COR
Cencora
4.4925 of 5 stars
$296.68
+0.5%
$306.33
+3.3%
+30.8%$57.47B$638.56M34.4046,000Positive News
Analyst Forecast
DVA
DaVita
4.5125 of 5 stars
$143.51
+0.7%
$164.50
+14.6%
+2.6%$10.83B$12.82B14.2276,000Positive News
MDT
Medtronic
4.6434 of 5 stars
$89.70
-0.3%
$97.47
+8.7%
+10.2%$115.00B$33.54B24.7795,000Positive News
Analyst Forecast
Analyst Revision
ZBH
Zimmer Biomet
4.9543 of 5 stars
$93.73
-0.1%
$110.00
+17.4%
-14.5%$18.54B$7.68B20.7417,000Analyst Upgrade
ABT
Abbott Laboratories
4.9888 of 5 stars
$132.59
+0.4%
$143.11
+7.9%
+15.3%$230.60B$42.34B17.19114,000Trending News
Earnings Report
Ex-Dividend
Analyst Forecast
Gap Down
BDX
Becton, Dickinson and Company
4.7738 of 5 stars
$176.29
+0.2%
$219.22
+24.4%
-22.8%$50.45B$20.87B33.5974,000Analyst Revision
EW
Edwards Lifesciences
4.3849 of 5 stars
$78.23
+0.2%
$80.40
+2.8%
-12.7%$45.90B$5.44B11.1815,800Positive News
Upcoming Earnings
Analyst Forecast

Related Companies and Tools


This page (NYSE:SYK) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners